Clinical Trials at Site 0241 - Florida Cancer Specialist - North
Site 0241 - Florida Cancer Specialist - North is a clinical research site in Lecanto, Florida that hosts paid clinical trials. Active studies at this site cover conditions such as Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung and Carcinoma, Non-Small-Cell Lung (NSCLC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
0 clinical trials at Site 0241 - Florida Cancer Specialist - North
·Clear filters·Common conditions studied in Lecanto
- Advanced Non-Small Cell Lung Cancer (1 active study)
- Carcinoma, Non-Small-Cell Lung (1 active study)
- Carcinoma, Non-Small-Cell Lung (NSCLC) (1 active study)
- High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer (1 active study)
- Lung Cancer (1 active study)
- Metastatic Non Small Cell Lung Cancer (1 active study)
Leading research sponsors in Lecanto
- Pfizer
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Frequently asked questions
How many paid clinical trials are currently recruiting in Lecanto?
There are approximately 3 recruiting clinical trials in Lecanto, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lecanto pay participants?
Most recruiting trials in Lecanto compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lecanto?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lecanto?
The most common conditions under active study in Lecanto include Advanced Non-Small Cell Lung Cancer (1), Carcinoma, Non-Small-Cell Lung (1), Carcinoma, Non-Small-Cell Lung (NSCLC) (1), High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lecanto?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lecanto on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lecanto?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lecanto?
Recruiting research sites in Lecanto include Florida Cancer Specialists, Site 0241 - Florida Cancer Specialist - North, West Coast Eye Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lecanto right now?
The largest active categories in Lecanto are Cancer & tumors (2), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.